Literature DB >> 2459956

Evaluation of staining methods for identifying Campylobacter pylori.

E Madan1, J Kemp, T U Westblom, M Subik, S Sexton, J Cook.   

Abstract

Campylobacter pylori has been implicated in the pathogenesis of peptide ulcer disease. The rapid identification of this organism may depend upon histologic diagnosis, because culture methods are complex and require a minimum of seven days in order to identify a negative specimen. The purpose of this study was to determine which stain used to identify this organism was the most cost-effective and easiest to perform and interpret on a routine basis. Sixty-one consecutive gastric antral biopsies were stained with hematoxylin and eosin, Giemsa, Brown-Brenn, and Warthin-Starry, with 23 of the cases stained by Brown-Hopps. Of the stains tested, the Wright-Giemsa was the easiest to perform. The organisms on the Wright-Giemsa showed a smooth, uniform purple color, whereas the Warthin-Starry gave the organism a granular appearance that at times could be confused for silver precipitate. Both the Wright-Giemsa and Brown-Hopps stain had the highest degree of identification of the organism (defined by percent positivity). The routine use of the Wright-Giemsa stain for identification of C. pylori in antral biopsies is recommended.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459956     DOI: 10.1093/ajcp/90.4.450

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  19 in total

1.  Evaluation of a commercially available complement fixation test for diagnosis of Helicobacter pylori infection and for follow-up after antimicrobial therapy.

Authors:  H Goossens; Y Glupczynski; A Burette; C Van den Borre; C DePrez; J Bodenmann; A Keller; J P Butzler
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Histopathological profile of gastritis in adult patients seen at a referral hospital in Kenya.

Authors:  Ahmed Kalebi; Farzana Rana; Walter Mwanda; Godfrey Lule; Martin Hale
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

Review 3.  Detection of infection or infectious agents by use of cytologic and histologic stains.

Authors:  G L Woods; D H Walker
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

Review 4.  Campylobacter pylori and gastroduodenal disease.

Authors:  G E Buck
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

5.  Diagnosis of Helicobacter pylori in biopsy specimens.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411

6.  Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial.

Authors:  Paul Kelly; Tamara Shawa; Stayner Mwanamakondo; Rose Soko; Geoff Smith; G Robin Barclay; Ian R Sanderson
Journal:  BMC Gastroenterol       Date:  2010-07-06       Impact factor: 3.067

7.  Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori.

Authors:  S H Phadnis; D Ilver; L Janzon; S Normark; T U Westblom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Significance of rapid urease test for identification of Helicobacter pylori in comparison with histological and culture studies.

Authors:  M Kawanishi; S Fukuda; H Kawaguchi; K Kohmoto; K Haruma; G Kajiyama
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

9.  Comparison of immunohistochemical and modified Giemsa stains for demonstration of Helicobacter pylori infection in an African population.

Authors:  H R Wabinga
Journal:  Afr Health Sci       Date:  2002-08       Impact factor: 0.927

10.  Long term serological surveillance after treatment of Helicobacter pylori infection.

Authors:  R A Veenendaal; A S Peña; J L Meijer; H P Endtz; M M van der Est; W van Duijn; F Eulderink; J Kreuning; C B Lamers
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.